awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q36263943-0CB89477-650B-49D0-9217-05732E4E2814
Q36263943-0CB89477-650B-49D0-9217-05732E4E2814
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36263943-0CB89477-650B-49D0-9217-05732E4E2814
Early BCR-ABL1 Transcript Decline after 1 Month of Tyrosine Kinase Inhibitor Therapy as an Indicator for Treatment Response in Chronic Myeloid Leukemia.
P2860
Q36263943-0CB89477-650B-49D0-9217-05732E4E2814
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36263943-0CB89477-650B-49D0-9217-05732E4E2814
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3d463017f33c458554bc4e644f4345eaadf0305d
P2860
Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: clinical results from a randomised phase-2 study (NordCML006).